AR and prostate carcinoma: Suppression of androgen receptor signaling in addition to apoptotic induction and cell cycle arrest in hepatocellular and prostatic carcinoma cells via the induction of p53 and p21(Waf/Cip-1) were also reported after fisetin treatment [43–45].